Newcastle Disease Virus (NDV)-based vaccine candidate against SARS-CoV-2 Omicron by intranasal immunization.
Antiviral Res
; 220: 105757, 2023 12.
Article
in En
| MEDLINE
| ID: mdl-37984567
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Blood Group Antigens
/
Vaccines
/
COVID-19
Limits:
Animals
/
Humans
Language:
En
Journal:
Antiviral Res
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: